USD 12.41
(-0.48%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 456.1 Million USD | -7.99% |
2022 | 495.7 Million USD | 49.89% |
2021 | 330.7 Million USD | -20.56% |
2020 | 416.3 Million USD | -22.1% |
2019 | 534.4 Million USD | -0.34% |
2018 | 536.2 Million USD | -45.31% |
2017 | 980.5 Million USD | 1.16% |
2016 | 969.3 Million USD | 2.58% |
2015 | 944.9 Million USD | -8.83% |
2014 | 1.03 Billion USD | 155.96% |
2013 | 404.9 Million USD | -15.38% |
2012 | 478.5 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 435.8 Million USD | 0.55% |
2024 Q1 | 433.4 Million USD | -4.98% |
2024 Q3 | 426.5 Million USD | -2.13% |
2023 Q3 | 502.8 Million USD | 16.42% |
2023 Q4 | 456.1 Million USD | -9.29% |
2023 FY | 456.1 Million USD | -7.99% |
2023 Q1 | 436.2 Million USD | -12.0% |
2023 Q2 | 431.9 Million USD | -0.99% |
2022 Q3 | 511.7 Million USD | 2.09% |
2022 Q2 | 501.2 Million USD | -1.73% |
2022 Q1 | 510 Million USD | 54.22% |
2022 FY | 495.7 Million USD | 49.89% |
2022 Q4 | 495.7 Million USD | -3.13% |
2021 FY | 330.7 Million USD | -20.56% |
2021 Q2 | 387 Million USD | -2.32% |
2021 Q1 | 396.2 Million USD | -4.83% |
2021 Q3 | 336 Million USD | -13.18% |
2021 Q4 | 330.7 Million USD | -1.58% |
2020 Q3 | 509.2 Million USD | 3.01% |
2020 Q4 | 416.3 Million USD | -18.24% |
2020 Q1 | 507.2 Million USD | -5.09% |
2020 FY | 416.3 Million USD | -22.1% |
2020 Q2 | 494.3 Million USD | -2.54% |
2019 Q2 | 506.5 Million USD | -8.56% |
2019 FY | 534.4 Million USD | -0.34% |
2019 Q4 | 534.4 Million USD | -1.18% |
2019 Q3 | 540.8 Million USD | 6.77% |
2019 Q1 | 553.9 Million USD | 3.3% |
2018 Q2 | 630.8 Million USD | -33.68% |
2018 Q3 | 544.3 Million USD | -13.71% |
2018 Q4 | 536.2 Million USD | -1.49% |
2018 Q1 | 951.1 Million USD | -3.0% |
2018 FY | 536.2 Million USD | -45.31% |
2017 Q2 | 968.1 Million USD | 1.32% |
2017 Q1 | 955.5 Million USD | -1.42% |
2017 Q3 | 968.2 Million USD | 0.01% |
2017 Q4 | 980.5 Million USD | 1.27% |
2017 FY | 980.5 Million USD | 1.16% |
2016 Q4 | 969.3 Million USD | -2.44% |
2016 Q3 | 993.5 Million USD | -2.84% |
2016 Q2 | 1.02 Billion USD | 8.79% |
2016 Q1 | 939.9 Million USD | -0.53% |
2016 FY | 969.3 Million USD | 2.58% |
2015 Q3 | 965.3 Million USD | 0.17% |
2015 FY | 944.9 Million USD | -8.83% |
2015 Q2 | 963.7 Million USD | -5.94% |
2015 Q1 | 1.02 Billion USD | -1.14% |
2015 Q4 | 944.9 Million USD | -2.11% |
2014 Q1 | 359.9 Million USD | -11.11% |
2014 Q4 | 1.03 Billion USD | 179.81% |
2014 Q2 | 379 Million USD | 5.31% |
2014 FY | 1.03 Billion USD | 155.96% |
2014 Q3 | 370.4 Million USD | -2.27% |
2013 FY | 404.9 Million USD | -15.38% |
2013 Q4 | 404.9 Million USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | 478.5 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Abbott Laboratories | 34.38 Billion USD | 98.674% |
Allurion Technologies Inc. | 142.19 Million USD | -220.748% |
Artivion, Inc. | 510.61 Million USD | 10.677% |
Butterfly Network, Inc. | 84.22 Million USD | -441.551% |
Butterfly Network, Inc. | 84.22 Million USD | -441.551% |
Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 87.181% |
Boston Scientific Corporation | 15.6 Billion USD | 97.077% |
CONMED Corporation | 1.46 Billion USD | 68.884% |
Edwards Lifesciences Corporation | 2.64 Billion USD | 82.748% |
Paragon 28, Inc. | 162.95 Million USD | -179.888% |
Glaukos Corporation | 478.64 Million USD | 4.711% |
Globus Medical, Inc. | 1.08 Billion USD | 58.084% |
Inspire Medical Systems, Inc. | 104.29 Million USD | -337.309% |
Integer Holdings Corporation | 1.41 Billion USD | 67.726% |
Medtronic plc | 39.56 Billion USD | 98.847% |
Myomo, Inc. | 5.59 Million USD | -8055.977% |
Nevro Corp. | 330.31 Million USD | -38.082% |
Owlet, Inc. | 73.79 Million USD | -518.03% |
Penumbra, Inc. | 377.36 Million USD | -20.866% |
Vicarious Surgical Inc. | 21.89 Million USD | -1983.124% |
Smith & Nephew plc | 4.77 Billion USD | 90.438% |
Sonendo, Inc. | 49.74 Million USD | -816.95% |
STERIS plc | 4.74 Billion USD | 90.395% |
Stryker Corporation | 21.31 Billion USD | 97.861% |
Vapotherm, Inc. | 132.95 Million USD | -243.059% |
Zimmer Biomet Holdings, Inc. | 9 Billion USD | 94.937% |